Indication
Acromegaly
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma. Read more about Acromegaly
48 drugs 41 manufacturers
Drugs that treat it
Common Acromegaly therapies.
BROMOCRIPTINE MESYLATE
LANREOTIDE ACETATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma.
Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth.
Patients classically develop coarse facial features, prognathism, macroglossia, and enlargement of the hands and feet.
If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis.
- nih.gov
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth Patients classically develop coarse facial features, prognathism, macroglossia, and enlargeme...
- endocrine.org
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth
- guidelinecentral.com
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth If unaddressed, sustained hormone elevation contributes to multi-organ system complications, ...
- nih.gov
Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis
- karger.com
Patients classically develop coarse facial features, prognathism, macroglossia, and enlargement of the hands and feet
- mayoclinic.org
If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis
Personalize your experience
Follow Acromegaly and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.